These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2956754)

  • 21. Clinical and pathological effects of the dermonecrotic toxin of Bordetella bronchiseptica and Pasteurella multocida in specific-pathogen-free piglets.
    Eliás B; Boros G; Albert M; Tuboly S; Gergely P; Papp L; Barna Vetró I; Rafai P; Molnár E
    Nihon Juigaku Zasshi; 1990 Aug; 52(4):677-88. PubMed ID: 2144027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of a Bordetella live vaccine on the occurrence and manifestation of atrophic rhinitis suum and the aerogenous infection burden in field strains of the agent].
    Ehser U; Mehlhorn G; Mietke H
    Dtsch Tierarztl Wochenschr; 1993 Sep; 100(9):355-9. PubMed ID: 8223236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets.
    Kobisch M; Novotny P
    Infect Immun; 1990 Feb; 58(2):352-7. PubMed ID: 2137111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type AP. multocida.
    Sakano T; Okada M; Taneda A; Mukai T; Sato S
    J Vet Med Sci; 1997 Jan; 59(1):55-7. PubMed ID: 9035080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of six different regimens for the control of atrophic rhinitis in swine.
    Pejsak Z; Hogg A; Wasińska B; Foreman K
    Zentralbl Veterinarmed B; 1990 Oct; 37(8):593-8. PubMed ID: 2220195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrophic rhinitis vaccine composition triggers different serological profiles that do not correlate with protection.
    Magyar T; Donkó T; Kovács F
    Acta Vet Hung; 2008 Mar; 56(1):27-40. PubMed ID: 18401954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses of piglets to Pasteurella multocida toxin and toxoid.
    van Diemen PM; de Vries Reilingh G; Parmentier HK
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):307-21. PubMed ID: 7941310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica.
    Rajeev S; Nair RV; Kania SA; Bemis DA
    Vet Microbiol; 2003 Jul; 94(4):313-23. PubMed ID: 12829385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Field trial for control of atrophic rhinitis by vaccination with Bordetella bronchiseptica].
    Keller H; Loretz H
    Schweiz Arch Tierheilkd; 1980 Oct; 122(10):541-51. PubMed ID: 7466336
    [No Abstract]   [Full Text] [Related]  

  • 30. Inoculation experiments with Bordetella bronchiseptica strains in SPF pigs.
    Tornoe N; Nielsen NC
    Nord Vet Med; 1976; 28(4-5):233-42. PubMed ID: 934809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virulence of Bordetella bronchiseptica from pigs with or without atrophic rhinitis.
    Rutter JM; Francis LM; Sansom BF
    J Med Microbiol; 1982 Feb; 15(1):105-16. PubMed ID: 7143418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal infection with Bordetella bronchiseptica in gnotobiotic piglets.
    Brassinne M; Dewaele A; Gouffaux M
    Res Vet Sci; 1976 Mar; 20(2):162-6. PubMed ID: 1265353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parenteral vaccination of young swine against Bordetella bronchiseptica.
    Farrington DO; Switzer WP
    Am J Vet Res; 1979 Oct; 40(10):1347-51. PubMed ID: 525851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. aroA deleted Bordetella bronchiseptica inspiring robust mucosal immune response and provide full protection against intranasal challenge.
    Zhang Q; Hu R; Hu J; He H; Tang X; Jin M; Chen H; Wu B
    Res Vet Sci; 2013 Feb; 94(1):55-61. PubMed ID: 22892249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vaccination against rhinitis atrophicans].
    Wittkowski G; Horner M; Tenhumberg H
    Berl Munch Tierarztl Wochenschr; 1980 Jun; 93(11):214-8. PubMed ID: 7406835
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum haptoglobin concentration in growing swine after intranasal challenge with Bordetella bronchiseptica and toxigenic Pasteurella multocida type D.
    Francisco CJ; Shryock TR; Bane DP; Unverzagt L
    Can J Vet Res; 1996 Jul; 60(3):222-7. PubMed ID: 8809387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Bordetella bronchiseptica bacterin in controlling enzootic atrophic rhinitis in swine.
    Goodnow RA; Shade FJ; Switzer WP
    Am J Vet Res; 1979 Jan; 40(1):58-60. PubMed ID: 453686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The aetiological significance of Bordetella bronchiseptica and Pasteurella multocida in atrophic rhinitis of swine.
    Pedersen KB; Barfod K
    Nord Vet Med; 1981 Dec; 33(12):513-22. PubMed ID: 7335484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.
    Rutter JM
    Res Vet Sci; 1983 May; 34(3):287-95. PubMed ID: 6878879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of piglets against atrophic rhinitis by vaccinating the sow with a vaccine against Pasteurella multocida and Bordetella bronchiseptica.
    Riising HJ; van Empel P; Witvliet M
    Vet Rec; 2002 May; 150(18):569-71. PubMed ID: 12019649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.